A.P. Pharma, Inc. Share Price Other OTC
Equities
US00202J2033
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Sales 2024 * | 148M 11.65B | Sales 2025 * | 178M 14.02B | Capitalization | 413M 32.54B |
---|---|---|---|---|---|
Net income 2024 * | -14M -1.1B | Net income 2025 * | 1M 78.82M | EV / Sales 2024 * | 2.79 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.32 x |
P/E ratio 2024 * |
-30.4
x | P/E ratio 2025 * |
411
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on A.P. Pharma, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 20/02/23 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 15/06/23 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 31/10/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 20/02/23 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 19/09/21 |
Craig Johnson
BRD | Director/Board Member | 62 | 12/01/14 |
1st Jan change | Capi. | |
---|---|---|
+17.72% | 44.44B | |
-10.33% | 37.99B | |
+37.55% | 37.75B | |
+29.36% | 30.78B | |
-8.44% | 27.38B | |
+12.45% | 26.17B | |
+44.19% | 14.15B | |
+31.93% | 12.59B | |
-7.67% | 11.28B |